EMBL grants exclusive technology license to Geneva Biotech

The European Molecular Biology Laboratory (EMBL), Europe’s flagship laboratory for basic research in molecular biology, has granted Geneva Biotech an exclusive license for intellectual property covering a portfolio of protein expression technologies. The company has also concluded a research collaboration agreement with EMBL.

Leave a Reply